POKONZA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pokonza, and what generic alternatives are available?
Pokonza is a drug marketed by Genus and is included in one NDA.
The generic ingredient in POKONZA is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pokonza
A generic version of POKONZA was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POKONZA?
- What are the global sales for POKONZA?
- What is Average Wholesale Price for POKONZA?
Summary for POKONZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| What excipients (inactive ingredients) are in POKONZA? | POKONZA excipients list |
| DailyMed Link: | POKONZA at DailyMed |
Pharmacology for POKONZA
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for POKONZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus | POKONZA | potassium chloride | FOR SOLUTION;ORAL | 208019-002 | Aug 25, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
